163 related articles for article (PubMed ID: 18566137)
1. Attenuation of Pseudomonas aeruginosa virulence by medicinal plants in a Caenorhabditis elegans model system.
Adonizio A; Leal SM; Ausubel FM; Mathee K
J Med Microbiol; 2008 Jul; 57(Pt 7):809-813. PubMed ID: 18566137
[TBL] [Abstract][Full Text] [Related]
2. Swietenia macrophylla extract promotes the ability of Caenorhabditis elegans to survive Pseudomonas aeruginosa infection.
Dharmalingam K; Tan BK; Mahmud MZ; Sedek SA; Majid MI; Kuah MK; Sulaiman SF; Ooi KL; Khan NA; Muhammad TS; Tan MW; Shu-Chien AC
J Ethnopharmacol; 2012 Jan; 139(2):657-63. PubMed ID: 22193176
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa PA14 pathogenesis in Caenorhabditis elegans.
Kirienko NV; Cezairliyan BO; Ausubel FM; Powell JR
Methods Mol Biol; 2014; 1149():653-69. PubMed ID: 24818940
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of quorum sensing-controlled virulence factor production in Pseudomonas aeruginosa by South Florida plant extracts.
Adonizio A; Kong KF; Mathee K
Antimicrob Agents Chemother; 2008 Jan; 52(1):198-203. PubMed ID: 17938186
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of quorum-sensing-controlled virulence factors of Pseudomonas aeruginosa by Murraya koenigii essential oil: a study in a Caenorhabditis elegans infectious model.
Ganesh PS; Rai RV
J Med Microbiol; 2016 Dec; 65(12):1528-1535. PubMed ID: 27902410
[TBL] [Abstract][Full Text] [Related]
6. An efficient and novel screening model for assessing the bioactivity of extracts against multidrug-resistant Pseudomonas aeruginosa using Caenorhabditis elegans.
Zhou YM; Shao L; Li JA; Han LZ; Cai WJ; Zhu CB; Chen DJ
Biosci Biotechnol Biochem; 2011; 75(9):1746-51. PubMed ID: 21897025
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide identification of Pseudomonas aeruginosa virulence-related genes using a Caenorhabditis elegans infection model.
Feinbaum RL; Urbach JM; Liberati NT; Djonovic S; Adonizio A; Carvunis AR; Ausubel FM
PLoS Pathog; 2012; 8(7):e1002813. PubMed ID: 22911607
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of phytochemicals from medicinal plants of Myrtaceae family on virulence factor production by Pseudomonas aeruginosa.
Musthafa KS; Sianglum W; Saising J; Lethongkam S; Voravuthikunchai SP
APMIS; 2017 May; 125(5):482-490. PubMed ID: 28294414
[TBL] [Abstract][Full Text] [Related]
9. Exopolysaccharide-Repressing Small Molecules with Antibiofilm and Antivirulence Activity against Pseudomonas aeruginosa.
van Tilburg Bernardes E; Charron-Mazenod L; Reading DJ; Reckseidler-Zenteno SL; Lewenza S
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223377
[TBL] [Abstract][Full Text] [Related]
10. Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model.
Sánchez-Diener I; Zamorano L; López-Causapé C; Cabot G; Mulet X; Peña C; Del Campo R; Cantón R; Doménech-Sánchez A; Martínez-Martínez L; Arcos SC; Navas A; Oliver A
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923877
[TBL] [Abstract][Full Text] [Related]
11. The roles of mucD and alginate in the virulence of Pseudomonas aeruginosa in plants, nematodes and mice.
Yorgey P; Rahme LG; Tan MW; Ausubel FM
Mol Microbiol; 2001 Sep; 41(5):1063-76. PubMed ID: 11555287
[TBL] [Abstract][Full Text] [Related]
12. The Pseudomonas aeruginosa PA14 type III secretion system is expressed but not essential to virulence in the Caenorhabditis elegans-P. aeruginosa pathogenicity model.
Wareham DW; Papakonstantinopoulou A; Curtis MA
FEMS Microbiol Lett; 2005 Jan; 242(2):209-16. PubMed ID: 15621439
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of HepP: a virulence-related Pseudomonas aeruginosa heparinase.
Dzvova N; Colmer-Hamood JA; Griswold JA; Hamood AN
BMC Microbiol; 2017 Dec; 17(1):233. PubMed ID: 29246112
[TBL] [Abstract][Full Text] [Related]
14. Protocol for survival assay of Caenorhabditis elegans to Pseudomonas aeruginosa PA14 infection.
Liu J; Lei M; Wang M; Chen S; Tu H
STAR Protoc; 2024 Jun; 5(2):103070. PubMed ID: 38768031
[TBL] [Abstract][Full Text] [Related]
15. Integrated whole-genome screening for Pseudomonas aeruginosa virulence genes using multiple disease models reveals that pathogenicity is host specific.
Dubern JF; Cigana C; De Simone M; Lazenby J; Juhas M; Schwager S; Bianconi I; Döring G; Eberl L; Williams P; Bragonzi A; Cámara M
Environ Microbiol; 2015 Nov; 17(11):4379-93. PubMed ID: 25845292
[TBL] [Abstract][Full Text] [Related]
16. A Dual-Specificity Inhibitor Targets Polyphosphate Kinase 1 and 2 Enzymes To Attenuate Virulence of Pseudomonas aeruginosa.
Neville N; Roberge N; Ji X; Stephen P; Lu JL; Jia Z
mBio; 2021 Jun; 12(3):e0059221. PubMed ID: 34126765
[TBL] [Abstract][Full Text] [Related]
17. Proteome analysis reveals translational inhibition of Caenorhabditis elegans enhances susceptibility to Pseudomonas aeruginosa PAO1 pathogenesis.
Balasubramanian V; Sellegounder D; Suman K; Krishnaswamy B
J Proteomics; 2016 Aug; 145():141-152. PubMed ID: 27109352
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors.
Tan MW; Rahme LG; Sternberg JA; Tompkins RG; Ausubel FM
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2408-13. PubMed ID: 10051655
[TBL] [Abstract][Full Text] [Related]
19. Caenorhabditis elegans semi-automated liquid screen reveals a specialized role for the chemotaxis gene cheB2 in Pseudomonas aeruginosa virulence.
Garvis S; Munder A; Ball G; de Bentzmann S; Wiehlmann L; Ewbank JJ; Tümmler B; Filloux A
PLoS Pathog; 2009 Aug; 5(8):e1000540. PubMed ID: 19662168
[TBL] [Abstract][Full Text] [Related]
20. Caenorhabditis elegans reveals novel Pseudomonas aeruginosa virulence mechanism.
Utari PD; Quax WJ
Trends Microbiol; 2013 Jul; 21(7):315-6. PubMed ID: 23684150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
